BELFB Stock Analysis: Bel Fuse | NASDAQ
Electronic Components | NASDAQ, USA | Market Cap: 3.604m USD | 12M Return: 77.3% | US0773473006 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 35.9M
EPS Trend: 19.3%
Qual. Beats: -1
Rev. Trend: 45.3%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Bel Fuse Inc. designs, manufactures, and markets components that power, protect, and connect electronic circuits, operating through three product groups: Power Solutions and Protection, Connectivity Solutions, and Magnetic Solutions. The company serves a diverse range of end markets including networking, telecommunications, computing, industrial, aerospace, defense, transportation, and e-Mobility, giving it broad exposure across both commercial and cyclical sectors.
Its product portfolio spans front-end and board-mount power supplies, circuit protection devices, fiber optic and copper-based connectors, RF and microwave components, as well as power transformers, inductors, and integrated connector modules. The company distributes its products globally through a combination of direct account managers, independent sales representatives, and authorized distributors across North America, Europe, the Middle East, and Asia.
As an electronic components manufacturer classified within the GICS Information Technology sector, Bel Fuse operates as a B2B supplier selling primarily to OEMs and system integrators rather than directly to end consumers, with product demand tied to capital spending and electronics content growth across its served industries. The company was incorporated in 1949 and is headquartered in West Orange, New Jersey.
- Defense and aerospace demand boosts power protection segment
- Data center capex drives high-speed connectivity product orders
- Industrial cycle weakness pressures magnetic solutions margins
| Net Income: 60.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.75 > 1.0 |
| NWC/Revenue: 72.95% < 20% (prev 42.85%; Δ 30.10% < -1%) |
| CFO/TA 0.07 > 3% & CFO 83.5m > Net Income 60.4m |
| Net Debt (-65.6m) to EBITDA (129.9m): -0.51 < 3 |
| Current Ratio: 4.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (13.6m) vs 12m ago 8.40% < -2% |
| Gross Margin: 39.52% > 18% (prev 37.84%; Δ 1.68% > 0.5%) |
| Asset Turnover: 67.19% > 50% (prev 62.49%; Δ 4.70% > 0%) |
| Interest Coverage Ratio: 9.42 > 6 (EBIT TTM 103.0m / Interest Expense TTM 10.9m) |
| A: 0.43 (Total Current Assets 698.7m - Total Current Liabilities 155.9m) / Total Assets 1.26b |
| B: 0.35 (Retained Earnings 438.2m / Total Assets 1.26b) |
| C: 0.09 (EBIT TTM 103.0m / Avg Total Assets 1.11b) |
| D: 3.61 (Book Value of Equity 909.4m / Total Liabilities 252.2m) |
| Altman-Z'' = 8.36 = AAA |
| DSRI: 1.04 (Receivables 166.2m/127.6m, Revenue 744.1m/594.0m) |
| GMI: 0.96 (GM 37.84% / 39.52%) |
| AQI: 0.73 (AQ_t 0.38 / AQ_t-1 0.53) |
| SGI: 1.25 (Revenue 744.1m / 594.0m) |
| TATA: -0.02 (NI 60.4m - CFO 83.5m) / TA 1.26b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of September 27, 2026, the stock is trading at USD 252.69 with a total of 140,874 shares traded. Over the past week, the price has changed by +4.43%, over one month by +1.04%, over three months by -18.55% and over the past year by +77.30%.
Current recommended Stop Loss: 239.10 (which is 5.4% or 1.3 ATR below the current price).
Bel Fuse has received a consensus analysts rating of 4.80. Therefore, it is recommended to buy BELFB.
- StrongBuy: 4
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 329.7 | 30.5% |
P/E Trailing = 62.5464
P/E Forward = 25.3165
P/S = 4.8428
P/B = 3.8621
P/EG = 1.6891
Revenue TTM = 744.1m USD
EBIT TTM = 103.0m USD
EBITDA TTM = 129.9m USD
Long Term Debt = 197.5m USD (from longTermDebt, last fiscal year)
Short Term Debt = 8.75m USD (from shortTermDebt, last quarter)
Debt = 240.5m USD (corrected: LT Debt 197.5m + ST Debt 8.75m) + Leases 34.3m
Net Debt = -65.6m USD (calculated: Debt 240.5m - CCE 306.1m)
Enterprise Value = 3.54b USD (3.60b + Debt 240.5m - CCE 306.1m)
Interest Coverage Ratio = 9.42 (Ebit TTM 103.0m / Interest Expense TTM 10.9m)
EV/FCF = 48.24x (Enterprise Value 3.54b / FCF TTM 73.3m)
FCF Yield = 2.07% (FCF TTM 73.3m / Enterprise Value 3.54b)
FCF Margin = 9.86% (FCF TTM 73.3m / Revenue TTM 744.1m)
Net Margin = 8.12% (Net Income TTM 60.4m / Revenue TTM 744.1m)
Gross Margin = 39.52% ((Revenue TTM 744.1m - Cost of Revenue TTM 450.0m) / Revenue TTM)
Gross Margin QoQ = 39.85% (prev 38.99%)
Tobins Q-Ratio = 2.80 (Enterprise Value 3.54b / Total Assets 1.26b)
Interest Expense / Debt = 4.55% (Interest Expense 10.9m / Debt 240.5m)
Taxrate = 16.28% (15.2m / 93.1m)
NOPAT = 86.3m (EBIT 103.0m * (1 - 16.28%))
Current Ratio = 4.48 (Total Current Assets 698.7m / Total Current Liabilities 155.9m)
Debt / Equity = 0.26 (Debt 240.5m / totalStockholderEquity, last quarter 909.4m)
Debt / EBITDA = -0.51 (Net Debt -65.6m / EBITDA 129.9m)
Debt / FCF = -0.89 (Net Debt -65.6m / FCF TTM 73.3m)
Total Stockholder Equity = 550.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.45% (Net Income 60.4m / Total Assets 1.26b)
RoE = 10.97% (Net Income TTM 60.4m / Total Stockholder Equity 550.4m)
RoCE = 13.78% (EBIT 103.0m / Capital Employed (Equity 550.4m + L.T.Debt 197.5m))
RoIC = 7.99% (NOPAT 86.3m / Invested Capital 1.08b)
WACC = 12.01% (E(3.60b)/V(3.84b) * Re(12.56%) + D(240.5m)/V(3.84b) * Rd(4.55%) * (1-Tc(0.16)))
Discount Rate = 12.56% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 48.65 | Cagr: 4.07%
[DCF] Terminal Value 67.07% ; FCFF base≈63.2m ; Y1≈72.5m ; Y5≈106.7m
[DCF] Fair Price = 84.17 (EV 971.7m - Net Debt -65.6m = Equity 1.04b / Shares 12.3m; r=12.01% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 19.35 | EPS CAGR: 2.78% | SUE: -1.04 | # QB: -1
Revenue Correlation: 45.33 | Revenue CAGR: 5.81% | SUE: 0.51 | # QB: 0
EPS current Quarter (2026-09-30): EPS=2.61 | Chg30d=+8.78% | Revisions=+29% | Analysts=8
EPS current Year (2026-12-31): EPS=9.83 | Chg30d=+13.78% | Revisions=+29% | GrowthEPS=+38.5% | GrowthRev=+20.0%
EPS next Year (2027-12-31): EPS=10.68 | Chg30d=+5.43% | Revisions=+29% | GrowthEPS=+8.6% | GrowthRev=+8.2%
[Analyst] Revisions Ratio: +40% (up=9, down=3)